{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T01:14:18Z","timestamp":1740100458570,"version":"3.37.3"},"reference-count":30,"publisher":"IEEE","license":[{"start":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/ieeexplore.ieee.org\/Xplorehelp\/downloads\/license-information\/IEEE.html"},{"start":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,9]]},"DOI":"10.1109\/bibm52615.2021.9669586","type":"proceedings-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T20:40:30Z","timestamp":1642192830000},"page":"1881-1885","source":"Crossref","is-referenced-by-count":0,"title":["Meta-Analysis of irAEs between Dose of CTLA-4 and PD-1 Inhibitors"],"prefix":"10.1109","author":[{"given":"Jingjie","family":"Qian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiyue","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"263","reference":[{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01281-7"},{"key":"ref10","article-title":"Current status and perspectives in translational biomarker research for PD-1\/PD-L1 immune checkpoint blockade therapy","volume":"9","author":"ma","year":"2016","journal-title":"Hematological Oncology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0712"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.11.016"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)70122-1"},{"key":"ref14","article-title":"Mucosal-Associated Invariant T (MAIT) Cell Dysfunction and PD-1 Expression in Prostate Cancer: Implications for Immunotherapy","volume":"12","author":"jarvis","year":"4142","journal-title":"Front Immunol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602252"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)70076-8"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504627"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1507643"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30498-3"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.0775"},{"key":"ref4","article-title":"Immune Checkpoint Inhibitors in Human Glioma Microenvironment","volume":"12","author":"ghouzlani","year":"2664","journal-title":"Front Immunol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2307\/2533446"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.716710"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.394"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00083-2"},{"key":"ref5","article-title":"Serum PD-1\/PDL1 Levels, Tumor Expression and PD-L1 Somatic Mutations in HER2-Positive and Triple Negative Normal-Like Feline Mammary Carcinoma Subtypes","volume":"12","author":"nascimento","year":"1386","journal-title":"Cancers"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12880"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-16-0237"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13081794"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0507"},{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9010286"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaa036"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-021-04307-0"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btz254"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1159\/000517502"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30231-0"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.58"}],"event":{"name":"2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM)","start":{"date-parts":[[2021,12,9]]},"location":"Houston, TX, USA","end":{"date-parts":[[2021,12,12]]}},"container-title":["2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM)"],"original-title":[],"link":[{"URL":"http:\/\/xplorestaging.ieee.org\/ielx7\/9669261\/9669139\/09669586.pdf?arnumber=9669586","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T16:57:08Z","timestamp":1652201828000},"score":1,"resource":{"primary":{"URL":"https:\/\/ieeexplore.ieee.org\/document\/9669586\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,9]]},"references-count":30,"URL":"https:\/\/doi.org\/10.1109\/bibm52615.2021.9669586","relation":{},"subject":[],"published":{"date-parts":[[2021,12,9]]}}}